SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

For the month of December 2019

Commission File Number 001-37410

ESSA Pharma Inc.

(Translation of registrant’s name into English)

Suite 720, 999 West Broadway, Vancouver, British Columbia, Canada, V5Z 1K5

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

 

 

 

 
 

 

EXPLANATORY NOTE

 

The following exhibits included herein were filed by the Registrant with the Canadian securities regulatory authorities on the System for Electronic Document Analysis and Retrieval on the dates noted below:

 

1. Exhibit 99.1: News Release Dated December 19, 2019: ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2019

 

This report on Form 6-K shall be incorporated by reference into the registrant’s Registration Statements on Form F-3 (File No. 333-222654) and Form S-8 (File No. 333-225056) under the Securities Act of 1933, as amended.

 

 

 

 

EXHIBITS INCLUDED AS PART OF THIS REPORT

 

   
Exhibit  
   
99.1 News Release Dated December 19, 2019: ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2019

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

             
   

ESSA PHARMA INC.

    (Registrant)
     
Date: December 19, 2019   By:  

/S/ DAVID WOOD

   

Name:

Title:

 

David Wood

Chief Financial Officer

 

ESSA Pharma (NASDAQ:EPIX)
Historical Stock Chart
From Apr 2020 to May 2020 Click Here for more ESSA Pharma Charts.
ESSA Pharma (NASDAQ:EPIX)
Historical Stock Chart
From May 2019 to May 2020 Click Here for more ESSA Pharma Charts.